Rely on our Proven Expertise for Successful Outcomes for your Non-Interventional Studies
Non-Interventional Studies (NIS) are helpful to examine the safety, tolerability and effectiveness of your medical product in market. Important findings like drug interactions, side effects, patience compliance, quality of life improvements and much more may be discovered through NIS. Such findings enable you to leverage your product to the maximum and improve the lives of patients.
Navitas Life Sciences is Your Partner in Non-Interventional Studies
Comprehensive NIS Capabilities to Meet Your Specific Needs
End-to-end Services from Study Setup to Closure
Wide Range of Therapeutic Expertise including Oncology & Neurology
Ability to handle both small studies and large studies ranging from 50 to 26,000+ patients
Extensive Geographical Coverage of Europe, CIS and Turkey with localized expertise
We Support Your End-to-End NIS Requirements
Design & plan your prospective or retrospective study with our experts to ensure successful outcomes
Your non-interventional studies are conducted in real life situations, requiring the right experience and expertise for successful completion
Data Standardization & Analysis
Expert biostatisticians are available to standardize and analyze your study data
Our regulatory submissions services are backed by a cutting-edge technology platform that enables first-time-right submissions and follow ups.
Bring patient safety to the forefront with our expert pharmacovigilance services and systems
Well-handled study closures with focus on data cleaning; country, and site closure procedures, Final QC of files, and publications
Drive Successful Outcomes for Your NIS Studies with our Expertise Across Multiple Study Types
We have conducted various types of studies, from market surveys, pre-launch screenings, classical Non-Interventional Studies, post-authorization safety studies, and post authorization effectiveness studies. We have helped our clients collect prospective and retrospective data for marketed products, evaluate product effectiveness, patient compliance, patient/physician satisfaction; identify, characterize and quantify safety hazards; confirm safety profile of medicinal products; and even measure the effectiveness of risk-management measures. We cover all aspects of post-marketing safety services, including generation of ICSRs, query management, ICSR to CA and Eudravigilance, and periodic safety reports. Our insight and understanding about each aspect of non-interventional studies, helps us deliver high quality outcomes to meet your specific needs.
- Market Surveys
- Pre-Launch Screening
- Post Authorization Safety Studies (PASS)
- Post authorization Efficacy Studies (PAES)
- Traditional Non-Interventional Studies (NIS)